Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vitamin litigation

This article was originally published in The Tan Sheet

Executive Summary

Notification program alerting indirect vitamin purchasers of eligibility to participate in $225 mil. vitamin price fixing settlement will begin this month, the Office of the Attorney General for New York announces Sept. 5. Notices will appear in print ads in national consumer, business and industry trade magazines; state-based and national newspapers; newspaper supplements; the Internet; and through communication with trade associations and the targeted industries. Hoffman-La Roche, BASF, Aventis Animal Nutrition, Takeda Chemical Industries, Eisai and Daiichi Pharmaceutical agreed to the settlement - which covers suits by Attorneys General of 21 states, the District of Columbia and Puerto Rico - last October (1"The Tan Sheet" Oct. 16, 2000, p. 5)

You may also be interested in...

Vitamin Price-Fixing $335 Mil. Settlement Reached For Indirect Purchasers

Twenty-four states and U.S. jurisdictions will use $145.6 mil. in proceeds from vitamin price-fixing settlements to fund health, education and scientific programs such as prenatal care and nutrition research.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts